Last reviewed · How we verify
SB-01 For Injection
SB-01 For Injection is a bone graft substitute used to promote bone growth and healing.
SB-01 For Injection is a bone graft substitute used to promote bone growth and healing. Used for Spinal fusion.
At a glance
| Generic name | SB-01 For Injection |
|---|---|
| Sponsor | Spine BioPharma, Inc |
| Drug class | Bone graft substitute |
| Modality | Small molecule |
| Therapeutic area | Orthopedics |
| Phase | Phase 3 |
Mechanism of action
It works by providing a scaffold for bone cells to attach and grow, allowing for the formation of new bone tissue. This process can help to repair damaged or diseased bone, such as in cases of spinal fusion or bone fractures.
Approved indications
- Spinal fusion
Common side effects
- Pain
- Swelling
- Infection
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- SB-01 For Injection CI brief — competitive landscape report
- SB-01 For Injection updates RSS · CI watch RSS
- Spine BioPharma, Inc portfolio CI